Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.
about
Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction.Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression.Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats.Orphan nuclear receptor SHP regulates iron metabolism through inhibition of BMP6-mediated hepcidin expression.FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation.Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation.Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells.Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis.TLR4 signaling and the inhibition of liver hepcidin expression by alcohol.AMPK: a novel target for treating hepatic fibrosisA vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.Circadian rhythmicity: A functional connection between differentiated embryonic chondrocyte-1 (DEC1) and small heterodimer partner (SHP).Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.The Effect of Chronic Inflammation and Oxidative and Endoplasmic Reticulum Stress in the Course of Metabolic Syndrome and Its Therapy
P2860
Q34044814-F17F6E5F-6364-4591-9984-77E8E0BC898EQ36041852-4508DF66-B4B6-4C65-B7C6-0847BF3BA94DQ36084908-B6A9FEC0-1DAA-4168-9EAF-C7BD688A8CCCQ36183112-AF45E165-FEBA-4945-92FC-0F1D11D146DAQ37298838-E1F44511-8A8B-4578-B111-47A90A302048Q37376356-7B9E283E-F2AE-401C-87D9-12B5E8BE5377Q37582435-A8A29F7B-0387-4471-89CB-FFB153BE415EQ38018381-FB35B3BB-B4B4-4DF8-8FAC-434CEF5A4AE1Q38874590-311BD345-599C-4A32-8DF0-1614A52BF882Q39057993-0BBE3176-D253-4048-B468-4F5EB7E30050Q40423409-BA954C2C-4900-489F-B14A-A91CBD2D3B78Q41847903-8F740A70-6982-4004-8520-D46D8E903B37Q42000401-57A1ABC6-85D2-4DE5-BCEA-5198B27C44FEQ42379258-37B97BD7-F09D-4C5A-A189-00457B3261FAQ47967476-FB70286D-8C28-4882-ACD6-7E37BBAB7EF1Q51284981-9831F10E-A360-4CAB-A198-3B504678C8F9Q58694047-6E00C181-8BE6-4E86-BD49-CE692B4A9C63
P2860
Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Metformin ameliorates IL-6-ind ...... partner (SHP) in mouse models.
@en
Metformin ameliorates IL-6-ind ...... ptor small heterodimer partner
@nl
type
label
Metformin ameliorates IL-6-ind ...... partner (SHP) in mouse models.
@en
Metformin ameliorates IL-6-ind ...... ptor small heterodimer partner
@nl
prefLabel
Metformin ameliorates IL-6-ind ...... partner (SHP) in mouse models.
@en
Metformin ameliorates IL-6-ind ...... ptor small heterodimer partner
@nl
P2093
P2860
P1433
P1476
Metformin ameliorates IL-6-ind ...... partner (SHP) in mouse models.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-012-2494-4
P577
2012-02-21T00:00:00Z